GB1419789A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
2-trifluoromethyl-4-quinolinols
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
NO179904C
(no)
|
1992-09-04 |
1997-01-08 |
Takeda Chemical Industries Ltd |
Kondenserte heterocykliske forbindelser og deres anvendelse
|
EP0683234B2
(en)
|
1993-01-25 |
2007-06-06 |
Takeda Chemical Industries, Ltd. |
Antibody against beta-amyloid or their derivative and use thereof
|
EP0733632B1
(en)
|
1995-03-24 |
2003-06-04 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds, their production and use as tachykinin receptor antagonists
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
NZ337765A
(en)
|
1997-04-09 |
2001-09-28 |
Mindset Biopharmaceuticals Usa |
Recombinant antibodies having specificity for beta-amyloid N-terminus and C-terminus and use in treating Alzheimer's Disease
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
EP1060141B1
(en)
|
1998-03-03 |
2002-10-30 |
PPG Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
AU1409100A
(en)
|
1998-11-27 |
2000-06-19 |
Takeda Chemical Industries Ltd. |
Drugs
|
AU4178601A
(en)
|
2000-02-24 |
2001-09-03 |
Univ Washington |
Humanized antibodies that sequester abeta peptide
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
WO2002042429A2
(en)
|
2000-11-03 |
2002-05-30 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
JP2006506352A
(ja)
|
2002-09-11 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害剤として有用なジヒドロキシピリドピラジン−1,6−ジオン化合物
|
JP2006519762A
(ja)
|
2002-10-09 |
2006-08-31 |
ライナット ニューロサイエンス コーポレイション |
アミロイドβペプチド及びその組成物に対する抗体を使用して、アルツハイマー病を治療する方法
|
CA2501799C
(en)
|
2002-10-09 |
2008-06-17 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
BRPI0410630A
(pt)
|
2003-06-19 |
2006-06-13 |
Pfizer Prod Inc |
antagonista de nk1
|
WO2005020991A1
(en)
|
2003-08-21 |
2005-03-10 |
Pfizer Products, Inc. |
Compounds for the treatment of neurodegenerative disorders
|
WO2005025616A1
(ja)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
抗体の用途
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
CA2554387A1
(en)
|
2004-01-28 |
2005-08-11 |
Merck & Co., Inc. |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
EP1720847A1
(en)
|
2004-02-02 |
2006-11-15 |
Pfizer Products Incorporated |
Histamine-3 receptor modulators
|
WO2005092099A1
(en)
|
2004-03-09 |
2005-10-06 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
BRPI0509069B8
(pt)
|
2004-03-23 |
2021-05-25 |
Pfizer Prod Inc |
compostos de imidazol e composição farmacêutica que os compreende para o tratamento de distúrbios neurodegenerativos
|
US20080076738A1
(en)
|
2004-04-14 |
2008-03-27 |
Cai Zhenhong R |
Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
EA016357B1
(ru)
|
2004-07-30 |
2012-04-30 |
Ринат Ньюросайенс Корп. |
Антитела, направленные против бета-амилоидного пептида, и способы их применения
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR TREATING TRAUMATIC BRAIN INJURY
|
MY148086A
(en)
|
2005-04-29 |
2013-02-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
EP1881825B1
(en)
|
2005-05-10 |
2013-07-24 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
US8227475B2
(en)
|
2005-05-12 |
2012-07-24 |
Pfizer Inc. |
Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
|
WO2006126082A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
ES2354569T3
(es)
|
2005-06-22 |
2011-03-16 |
Pfizer Products Inc. |
Antagonistas del receptor de histamina-3.
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
JP2009514846A
(ja)
|
2005-11-04 |
2009-04-09 |
ファイザー・リミテッド |
テトラヒドロナフチリジン誘導体
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
WO2007062332A2
(en)
|
2005-11-18 |
2007-05-31 |
Glaxo Group Limited |
Novel intermediates and their use
|
TWI386207B
(zh)
|
2005-11-24 |
2013-02-21 |
Eisai R&D Man Co Ltd |
味啉類型之肉桂醯胺化合物
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
BRPI0706685A2
(pt)
*
|
2006-01-20 |
2011-04-05 |
Schering Corp |
benzenosulfonil-cromano, tiocromano, tetraidronaftaleno e inibidores relacionados à secretase de gama
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
CA2643055A1
(en)
|
2006-03-13 |
2007-09-20 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
WO2007122466A1
(en)
|
2006-04-21 |
2007-11-01 |
Pfizer Products Inc. |
Pyridine[3,4-b]pyrazinones
|
AU2007254325B2
(en)
|
2006-05-15 |
2012-05-10 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
WO2007136714A2
(en)
|
2006-05-16 |
2007-11-29 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
CA2651396A1
(en)
|
2006-05-19 |
2007-11-29 |
Eisai R&D Management Co., Ltd. |
Urea type cinnamide derivative
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
CA2676456C
(en)
|
2007-01-22 |
2012-03-27 |
Pfizer Products Inc. |
Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
|
JP2010518083A
(ja)
|
2007-02-12 |
2010-05-27 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピペリジン誘導体
|
AU2008215948A1
(en)
|
2007-02-12 |
2008-08-21 |
Merck & Co., Inc. |
Piperazine derivatives for treatment of AD and related conditions
|
US20080207900A1
(en)
|
2007-02-28 |
2008-08-28 |
Teiji Kimura |
Two cyclic oxomorphorin derivatives
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
JP5209043B2
(ja)
|
2007-05-07 |
2013-06-12 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ガンマセクレターゼ調節剤
|
MX2009012163A
(es)
|
2007-05-11 |
2009-12-01 |
Hoffmann La Roche |
Hetarilanilinas como moduladores para beta-amiloide.
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
KR20100037053A
(ko)
|
2007-06-01 |
2010-04-08 |
쉐링 코포레이션 |
감마 세크레타제 조절인자
|
AU2008263206A1
(en)
|
2007-06-01 |
2008-12-18 |
Schering Corporation |
Gamma secretase modulators
|
US8242150B2
(en)
|
2007-06-13 |
2012-08-14 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treating alzheimer'S disease and related conditions
|
CA2692253A1
(en)
|
2007-06-29 |
2009-01-08 |
Schering Corporation |
Gamma secretase modulators
|
EP2185522A1
(en)
|
2007-08-06 |
2010-05-19 |
Schering Corporation |
Gamma secretase modulators
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
EP2181992B8
(en)
|
2007-08-31 |
2013-06-26 |
Eisai R&D Management Co., Ltd. |
Polycyclic compound
|
MX2010002674A
(es)
|
2007-09-06 |
2010-03-25 |
Schering Corp |
Moduladores de gamma secretasa.
|
AR068636A1
(es)
|
2007-09-28 |
2009-11-25 |
Schering Corp |
Moduladores de la gamma secretasa
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
JP2011503002A
(ja)
|
2007-11-05 |
2011-01-27 |
シェーリング コーポレイション |
γセクレターゼ調節剤
|
CA2707722A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Schering Corporation |
Gamma secretase modulators
|
MX2010006379A
(es)
|
2007-12-11 |
2010-09-07 |
Schering Corp |
Moduladores de la secretasa gamma.
|
EP2227471A1
(en)
|
2007-12-11 |
2010-09-15 |
Schering Corporation |
Gamma secretase modulators
|
WO2009075874A1
(en)
|
2007-12-13 |
2009-06-18 |
Amgen Inc. |
Gamma secretase modulators
|
BRPI0906799A2
(pt)
|
2008-01-11 |
2015-07-14 |
Hoffmann La Roche |
Moduladores para amiloide beta
|
CA2713716A1
(en)
|
2008-02-22 |
2009-08-27 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
US20110027264A1
(en)
|
2008-02-29 |
2011-02-03 |
Xianhai Huang |
Gamma secretase modulators for the treatment of alzheimer's disease
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
JP2011520809A
(ja)
|
2008-05-05 |
2011-07-21 |
アムジエン・インコーポレーテツド |
γセクレターゼモジュレーターとしての尿素化合物
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
EP2312946A4
(en)
|
2008-08-13 |
2012-10-24 |
Merck Sharp & Dohme |
PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
BRPI0917144A2
(pt)
|
2008-08-27 |
2015-08-04 |
Eisai R&D Man Co Ltd |
Processo para preparar compostos, processo para preparar uma mistura, sais de d-dbta, de d-dpta e de ácido (+) -n- (1-feniletila) ftalâmico ((+) -pepa), e, composto.
|
KR101324414B1
(ko)
|
2008-10-09 |
2013-11-01 |
에프. 호프만-라 로슈 아게 |
아밀로이드 베타의 조절자
|
JP2012508180A
(ja)
|
2008-11-06 |
2012-04-05 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
US20110257156A1
(en)
|
2008-11-06 |
2011-10-20 |
Zhaoning Zhu |
Gamma secretase modulators
|
CA2742897A1
(en)
|
2008-11-06 |
2010-05-14 |
Astrazeneca Ab |
Modulators of amyloid beta.
|
WO2010052199A1
(en)
|
2008-11-10 |
2010-05-14 |
F. Hoffmann-La Roche Ag |
Heterocyclic gamma secretase modulators
|
EP2379075A4
(en)
|
2008-12-16 |
2012-05-30 |
Merck Sharp & Dohme |
TRIAZOL DERIVATIVES FOR THE TREATMENT OF ALZHEIMER DISEASE
|
US8575150B2
(en)
|
2008-12-16 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of Alzheimer's disease
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
PE20120061A1
(es)
|
2008-12-19 |
2012-02-19 |
Boehringer Ingelheim Int |
Derivados de pirimidina como antagonistas del receptor ccr2
|
JP2012513399A
(ja)
|
2008-12-22 |
2012-06-14 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
JP2012513400A
(ja)
|
2008-12-22 |
2012-06-14 |
シェーリング コーポレイション |
γ−セクレターゼ調節剤
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
CA2748862A1
(en)
|
2009-02-06 |
2010-08-12 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
TWI461425B
(zh)
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
AU2010218667A1
(en)
|
2009-02-26 |
2011-07-21 |
Eisai R&D Management Co., Ltd. |
Salt of tetrahydrotriazolopyridine derivative and crystal thereof
|
EP2403835A1
(en)
|
2009-03-03 |
2012-01-11 |
Pfizer Inc. |
Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
|
WO2011017513A1
(en)
|
2009-08-07 |
2011-02-10 |
Dow Agrosciences Llc |
Pesticidal compositions
|
CA2776480A1
(en)
*
|
2009-10-20 |
2011-04-28 |
Pfizer Inc. |
Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
|
MX350761B
(es)
*
|
2009-12-22 |
2017-09-18 |
Vertex Pharma |
Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa.
|
JP5767393B2
(ja)
*
|
2011-03-31 |
2015-08-19 |
ファイザー・インク |
新規二環式ピリジノン
|
WO2013171712A1
(en)
*
|
2012-05-16 |
2013-11-21 |
Janssen Pharmaceuticals, Inc. |
Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer's disease
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙(氟烷基)-1,4-苯并二氮呯酮化合物及其前藥
|
CN104918938B
(zh)
|
2012-12-20 |
2017-08-15 |
詹森药业有限公司 |
新颖的作为γ分泌酶调节剂的三环3,4‑二氢‑2H‑吡啶并[1,2‑a]吡嗪‑1,6‑二酮衍生物
|
JP6283691B2
(ja)
|
2013-01-17 |
2018-02-21 |
ヤンセン ファーマシューティカ エヌ.ベー. |
γセクレターゼ調節剤としての新規な置換ピリド−ピペラジノン誘導体
|
ES2742078T3
(es)
|
2013-10-04 |
2020-02-13 |
Pfizer |
Piridonas bicíclicas novedosas como moduladores de gamma-secretasa
|
EP3119347B1
(en)
|
2014-03-21 |
2023-06-07 |
Align Technology, Inc. |
Segmented orthodontic appliance with elastics
|
MD20160102A2
(ro)
|
2014-04-01 |
2017-04-30 |
Pfizer Inc. |
Cromen şi 1,1a,2,7b-tetrahidrociclopropa[c]cromen piridopirazindione ca modulatori ai gama-secretazei
|